Malaria Chemoprevention at the 2025 ASTMH Annual Meeting

9-13 Nov 2025

Toronto, Canada

The American Society of Tropical Medicine & Hygiene (ASTMH) Annual Meeting is one of the leading global gatherings where research meets real-world application in the fields of tropical medicine and global health. This five-day conference brings together scientists, health professionals, policymakers, and implementers from across the world to exchange insights, share evidence, and shape the future of disease prevention and control.

The event features plenary sessions, scientific and clinical presentations, e-poster sessions, and an exhibit hall showcasing the latest innovations, tools, and services driving progress in global health.

At the 2025 ASTMH, the SMC Alliance will host key malaria chemoprevention-related sessions and subgroup meetings, providing an opportunity to engage with global experts and partners committed to advancing malaria prevention strategies.

To explore the 100+ posters on malaria chemoprevention that will be presented throughout the week, visit the 2025 ASTMH Conference App for full details.

See the table below for all the malaria chemoprevention-related events scheduled at the conference, as well as SMC Alliance subgroup meetings.

Date	Time	Event Title	Event Type	Venue	More Info
Monday, Nov 10	8:30 AM	8 - Addressing Research Gaps in Chemoprevention Targeting School-Aged Children	Symposium	Convention Center - Room 715 (Level 7)	LINK
	8:50 AM	6012 - Evaluating the real-world impact of Seasonal Malaria Chemoprevention (SMC) in Burkina Faso using a mathematical modelling framework, 2010 - 2018	Oral presentation	Convention Center - Room 701B (Level 7)	LINK
	9:00 AM	6013 - Optimization of SMC Campaigns through Digitalized Micro-Planning in DHIS2: Pilot Phase in Mali	Oral presentation	Convention Center - Room 701B (Level 7)	LINK
	10:55 AM	6090 - Innovations in mobile data capture for multi-country implementation of a longitudinal malaria chemoprevention study in Cameroon and Cote d’Ivoire	Oral presentation	Convention Center - Room 801A (Level 8)	LINK
	3:05 PM	6576 - Efficacy and safety of intermittent preventive treatment of malaria in school-age children using Sulfadoxine-pyrimethamine plus amodiaquine and Dihydroartemisinin-piperaquine plus Ivermectin in rural Burkina Faso.	Oral presentation	Convention Center - Room 701B (Level 700)	LINK

Tuesday, Nov 11	10:15 AM	70 - Antimalarial Drug Resistance in Africa: Will We Miss the Train Again? (includes presentations on chemoprevention)	Symposium	Convention Center - Room 715 (Level 7)	LINK
	2:55 PM	7167 - Barriers to Essential Programme on Immunisation Coverage and Implications for Perennial Malaria Chemoprevention in Infants: Evidence from census surveys in Cameroon and Côte d'Ivoire	Oral presentation	Convention Center - Room 801A (Level 8)	LINK
	4:00 PM	105 - Results from large-scale implementation of perennial malaria chemoprevention (PMC) in Benin, Cameroon, Côte d'Ivoire, Mozambique and Nigeria	Symposium	Convention Center - Room 718B (Level 7)	LINK
	4:10 PM	7190 - Geographical Variation in Sulfadoxine-Pyrimethamine Resistance Markers and Implications for Malaria Chemoprevention in Cameroon	Oral presentation	Convention Center - Room 701B (Level 7)	LINK
	4:20 PM	7191 - Phenotypic assessment of Plasmodium falciparum molecular markers associated with malaria chemoprevention in Senegal	Oral presentation	Convention Center - Room 701B (Level 7)	LINK

Wednesday, Nov 12	3:00 PM	152 - Delayed (post-intervention) Malaria - Should This be a Concern? (includes presentations on SMC)	Symposium	Convention Center - Room 718A (Level 7)	LINK
	3:20 PM	7794 - Key lessons from integrating SMC and a community-based catch-up strategy for pregnant women and children under five for ANC and immunization	Oral presentation	Convention Center - Room 701B (Level 7)	LINK
	3:30 PM	7795 - Strategic expansion of seasonal malaria chemoprevention in sub-Saharan Africa: insights from a model-based impact assessment	Oral presentation	Convention Center - Room 701B (Level 7)	LINK
	3:40 PM	7796 - Understanding and maximizing the community impact of seasonal malaria chemoprevention: a randomized controlled trial in a high malaria burden setting	Oral presentation	Convention Center - Room 701B (Level 7)	LINK
	4:10 PM	7799 - Delivery strategies to optimise adherence of post-discharge malaria chemoprevention (PDMC): Findings from formative research in Benin, Malawi, Kenya and Uganda	Oral presentation	Convention Center - Room 701B (Level 7)	LINK

Thursday, Nov 13	8:00 AM	7921 - Impact of early life malaria chemoprevention on immunogenicity of pneumococcal vaccination in childhood	Oral presentation	Convention Center - Room 701B (Level 7)	LINK
Thursday, Nov 13	8:15 AM	7932 - Antibody responses in children receiving seasonal malaria chemoprevention, RTS,S/AS01E vaccination, or both interventions during the first five years of life	Oral presentation	Convention Center - Room 716 (Level 7)	LINK

SMC

Optimising Seasonal Malaria Chemoprevention in West and Central Africa

Search

Malaria Chemoprevention at the 2025 ASTMH Annual Meeting

Download the event schedule

Contact us

Subscribe to newsletter